VanEck Biotech ETF (NASDAQ:BBH) Sets New 12-Month High – What’s Next?

VanEck Biotech ETF (NASDAQ:BBH)’s stock price reached a new 52-week high during trading on Thursday. The company traded as high as $269.90 and last traded at $260.3710, with a volume of 1,235 shares traded. The stock had previously closed at $261.63.

VanEck Biotech ETF Stock Up 1.0%

The company has a fifty day moving average of $242.34 and a 200-day moving average of $208.37.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Allworth Financial LP purchased a new position in shares of VanEck Biotech ETF during the 3rd quarter valued at $104,000. Fifth Third Bancorp purchased a new position in VanEck Biotech ETF in the third quarter worth approximately $165,000. Kestra Advisory Services LLC acquired a new position in VanEck Biotech ETF in the third quarter valued at approximately $788,000. Commonwealth Equity Services LLC acquired a new position in VanEck Biotech ETF in the 3rd quarter valued at about $1,009,000. Finally, Caldwell Trust Co purchased a new stake in shares of VanEck Biotech ETF during the third quarter valued at approximately $47,000. Institutional investors and hedge funds own 32.05% of the company’s stock.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.